Cargando…

Thyroid Hormone Withdrawal versus Recombinant Human TSH as Preparation for I-131 Therapy in Patients with Metastatic Thyroid Cancer: A Systematic Review and Meta-Analysis

SIMPLE SUMMARY: Differentiated thyroid carcinoma (DTC) is characterized by an excellent prognosis, with the exception of cases that develop in metastatic forms. Although I-131 has been shown to be an effective therapy in patients with metastatic DTC, whether its efficacy after recombinant human TSH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giovanella, Luca, Garo, Maria Luisa, Campenní, Alfredo, Petranović Ovčariček, Petra, Görges, Rainer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177224/ https://www.ncbi.nlm.nih.gov/pubmed/37173976 http://dx.doi.org/10.3390/cancers15092510

Ejemplares similares

Accuracy of papillary thyroid cancer prognostic nomograms: a systematic review
por: Luisa Garo, Maria, et al.
Publicado: (2023)

Molecular Imaging and Theragnostics of Thyroid Cancers
por: Giovanella, Luca, et al.
Publicado: (2022)

Comparison of 1.1 GBq and 2.2 GBq Activities in Patients with Low-Risk Differentiated Thyroid Cancer Requiring Postoperative (131)I Administration: A Real Life Study
por: Campennì, Alfredo, et al.
Publicado: (2023)

Prevalence of thyroid dysfunction in patients with COVID-19: a systematic review
por: Giovanella, Luca, et al.
Publicado: (2021)

SAT510 I-131 Therapy with Dosimetry for Advanced Thyroid Carcinoma: Recombinant TSH vs Thyroid Hormone Withdrawal
por: Awad, Dana, et al.
Publicado: (2023)

Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer
por: Petranović Ovčariček, Petra, et al.
Publicado: (2023)

The EANM guideline on radioiodine therapy of benign thyroid disease
por: Campennì, Alfredo, et al.
Publicado: (2023)

Comparison of I-131 Biokinetics after Recombinant Human TSH Stimulation and Thyroid Hormone Withdrawal Measured by External Detector in Patients with Differentiated Thyroid Cancer
por: Kairemo, Kalevi, et al.
Publicado: (2019)

Postoperative thyroglobulin as a yard-stick for radioiodine therapy: decision tree analysis in a European multicenter series of 1317 patients with differentiated thyroid cancer
por: Giovanella, Luca, et al.
Publicado: (2023)

The role of thyroglobulin doubling time in differentiated thyroid cancer: a meta-analysis
por: Giovanella, Luca, et al.
Publicado: (2022)

MON-LB87 Recombinant Human TSH vs Thyroid Hormone Withdrawal Preparation for Radioiodine Ablation in Pediatric Differentiated Thyroid Cancer
por: Schumm, Max A, et al.
Publicado: (2020)

Comparing the effectiveness of stimulation using rhTSH and thyroid hormone withdrawal in the treatment of thyroid cancer
por: Kowalska, Aldona
Publicado: (2015)

Five-Year Survival Is Similar in Thyroid Cancer Patients with Distant Metastases Prepared for Radioactive Iodine Therapy with either Thyroid Hormone Withdrawal or Recombinant Human TSH
por: Tala, H., et al.
Publicado: (2011)

Reference ranges for TSH and thyroid hormones
por: Lewandowski, Krzysztof
Publicado: (2015)

Recombinant Human Thyroid Stimulating Hormone versus Thyroid Hormone Withdrawal for Radioactive Iodine Treatment of Differentiated Thyroid Cancer with Nodal Metastatic Disease
por: Wolfson, Robert M., et al.
Publicado: (2016)

Feasibility of Recombinant Human TSH as a Preparation for Radioiodine Therapy in Patients with Distant Metastases from Papillary Thyroid Cancer: Comparison of Long-Term Survival Outcomes with Thyroid Hormone Withdrawal
por: Tsai, Hsi-Chen, et al.
Publicado: (2022)

The TSH/Thyroid Hormones Axis and Breast Cancer
por: Voutsadakis, Ioannis A.
Publicado: (2022)

TSH Pulses Finely Tune Thyroid Hormone Release and TSH Receptor Transduction
por: Guillou, Anne, et al.
Publicado: (2023)

Effect of withdrawal of thyroid hormones versus administration of recombinant human thyroid-stimulating hormone on renal function in thyroid cancer patients
por: An, Young-Sil, et al.
Publicado: (2023)

SAT-426 Macro-Thyroid Stimulating Hormone (TSH) in Children
por: Hattori, Naoki, et al.
Publicado: (2020)

Radioactive Body Burden Measurements in (131)Iodine Therapy for Differentiated Thyroid Cancer: Effect of Recombinant Thyroid Stimulating Hormone in Whole Body (131)Iodine Clearance
por: Ravichandran, Ramamoorthy, et al.
Publicado: (2014)

Economic Evaluation of Recombinant Human Thyroid Stimulating Hormone Stimulation vs. Thyroid Hormone Withdrawal Prior to Radioiodine Ablation for Thyroid Cancer: The Korean Perspective
por: Sohn, Seo Young, et al.
Publicado: (2015)

Reference intervals for thyroid‐stimulating hormone and thyroid hormones using the access TSH 3rd IS method in China
por: Li, Zhen‐Zhen, et al.
Publicado: (2020)

Does the use of recombinant TSH in preparation for I-131 scintigraphy scan affect hearing function?
por: Doğan, Mehtap, et al.
Publicado: (2018)

Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer
por: Pitoia, Fabián, et al.
Publicado: (2012)

Recombinant human TSH versus thyroid hormone withdrawal in adjuvant therapy with radioactive iodine of patients with papillary thyroid carcinoma and clinically apparent lymph node metastases not limited to the central compartment (cN1b)
por: Rosario, Pedro Weslley, et al.
Publicado: (2017)

Personalized management of differentiated thyroid cancer in real life – practical guidance from a multidisciplinary panel of experts
por: Campennì, Alfredo, et al.
Publicado: (2020)

A STUDY OF THYROID HORMONES (T(3), T(4) & TSH) IN PATIENTS OF DEPRESSION
por: Saxena, Jalal, et al.
Publicado: (2000)

Effects of bone marrow cell transplant on thyroid function in an I(131)-induced low T4 and elevated TSH rat model
por: Guajardo-Salinas, Gustavo E, et al.
Publicado: (2007)

Growth Hormone (GH) and Thyroid Stimulating Hormone (TSH) Co-Secreting Pituitary Macroadenoma
por: Maliakal, Alvin, et al.
Publicado: (2021)

Recurrence of Differentiated Thyroid Carcinoma During Full TSH Suppression: Is the Tumor Now Thyroid Hormone Dependent?
por: Davis, Paul J., et al.
Publicado: (2014)

The Effectiveness of Recombinant Human Thyroid-Stimulating Hormone versus Thyroid Hormone Withdrawal Prior to Radioiodine Remnant Ablation in Thyroid Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Pak, Kyoungjune, et al.
Publicado: (2014)

Hyponatremia after Thyroid Hormone Withdrawal in a Patient with Papillary Thyroid Carcinoma
por: Jo, Hyo Jin, et al.
Publicado: (2014)

Effect of salinity level on TSH and thyroid hormones of grass carp, Ctenophayngodon idella
por: Peyghan, Rahim, et al.
Publicado: (2013)

TSH-independent release of thyroid hormones through cold exposure in aging rats
por: Park, Gi Cheol, et al.
Publicado: (2017)

The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine
por: Antonelli, Alessandro, et al.
Publicado: (2021)

Iodine deficiency is associated with increased thyroid hormone sensitivity in individuals with elevated TSH
por: Sun, Ying, et al.
Publicado: (2022)

Association between thyroid-stimulating hormone (TSH) and proteinuria in relation to thyroid cyst in a euthyroid general population
por: Shimizu, Yuji, et al.
Publicado: (2021)

Long-Term Outcome of Differentiated Thyroid Cancer Patients—Fifty Years of Croatian Thyroid Disease Referral Centre Experience
por: Jukić, Tomislav, et al.
Publicado: (2022)

Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for (131)I Administration
por: Gomes-Lima, Cristiane J, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h43s7jd7s8omq9li2t4pp766ok